@article{8a40e39098284366a3ee881709c25486,
title = "The role of stewardship in addressing Antibacterial resistance: Stewardship and infection control committee of the Antibacterial Resistance Leadership Group",
abstract = "Antibacterial resistance is increasing globally and has been recognized as a major public health threat. Antibacterial stewardship is the coordinated effort to improve the appropriate use of antibiotics with the aim to decrease selective pressure for multidrug-resistant organisms in order to preserve the utility of antibacterial agents. This article describes the activities of the Antibacterial Resistance Leadership Group (ARLG) in the area of antibacterial stewardship. To date, the ARLG has focused intensely on development of rapid diagnostic tests, which (when coupled with educational and institutional initiatives) will enable the robust stewardship that is needed to address the current crisis of antibacterial resistance. In addition to exploring the effectiveness of stewardship techniques in community hospitals, the ARLG has also developed strategy trials to assess the feasibility of reducing antibacterial usage while preserving patient outcome.",
keywords = "Antibacterial resistance, Infection control, Stewardship",
author = "Anderson, {Deverick J.} and Jenkins, {Timothy C.} and Evans, {Scott R.} and Harris, {Anthony D.} and Weinstein, {Robert A.} and Tamma, {Pranita D.} and Han, {Jennifer H.} and Ritu Banerjee and Robin Patel and Theoklis Zaoutis and Ebbing Lautenbach",
note = "Funding Information: Financial support. This article was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH (award number UM1AI104681). Funding Information: merase chain reaction, device/method for sonication with royalties paid by Samsung to Mayo Clinic, anti-biofilm substance; has served on a data monitoring board for Actelion; and has received travel reimbursement and an editor{\textquoteright}s stipend from the American Society for Microbiology and IDSA and honoraria from the US Medical Licensing Examination, UpToDate, and the Infectious Diseases Board Review Course. T. Z. has received research funding from Merck and served as a consultant for Napriva. All other authors report no potential conflicts. The authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Publisher Copyright: {\textcopyright} The Author 2017.",
year = "2017",
doi = "10.1093/cid/ciw830",
language = "English (US)",
volume = "64",
pages = "S36--S40",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
}